NCT01865188View on ClinicalTrials.gov

Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Hypertension
Interventions
DRUG

LCZ696

Experimental monotherapy doses

DRUG

Amlodipine

Active comparator monotherapy doses

DRUG

LCZ696 and amlodipine combination

Experimental combination doses

DRUG

Placebo

Placebo comparator dose

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY